TALEN

TALEN1-pomca

ID
ZDB-TALEN-200609-1
Name
TALEN1-pomca
Previous Names
None
Target
Target Sequence 1
5' - GTTGGGAAAATGCCCGCT - 3'
Target Sequence 2
5' - CACCAAGATGTTCTCCTCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ihb408 pomca
ihb409 pomca
Expression
Gene expression in Wild Types + TALEN1-pomca
No data available
Phenotype
Phenotype resulting from TALEN1-pomca
No data available
Phenotype of all Fish created by or utilizing TALEN1-pomca
Phenotype Fish Conditions Figures
muscle glucose catabolic process decreased rate of occurrence, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
head kidney cyp17a1 expression increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
head kidney hsd17b3 expression increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
trunk musculature ab1-rps6 labeling increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
muscle fatty acid beta-oxidation increased occurrence, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
whole organism increased weight, abnormal pomcaihb408/ihb408 increased food availability Fig. 3 from Shi et al., 2019
whole organism increased weight, abnormal pomcaihb408/ihb408 standard conditions Fig. 3Fig. 4Fig. 6Table 2 from Shi et al., 2019
intestine lumen food increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 1 from Shi et al., 2019
hypophysis pomca expression decreased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 1 from Shi et al., 2019
exploration behavior decreased occurrence, abnormal pomcaihb408/ihb408 standard conditions Table 2 from Shi et al., 2019
hypothalamus pomca expression decreased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 1 from Shi et al., 2019
background adaptation disrupted, abnormal pomcaihb408/ihb408 standard conditions Fig. 1 from Shi et al., 2019
whole organism cortisol increased amount, abnormal pomcaihb408/ihb408 standard conditions Table 2 from Shi et al., 2019
trunk musculature ab5-akt labeling increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
whole organism increased weight, ameliorated pomcaihb408/ihb408 chemical treatment by environment: sirolimus Fig. 4 from Shi et al., 2019
head kidney hsd3b1 expression decreased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
interrenal gland hsd3b1 expression decreased distribution, abnormal pomcaihb408/ihb408 standard conditions Fig. 2 from Shi et al., 2019
response to light stimulus decreased magnitude, abnormal pomcaihb408/ihb408 standard conditions Fig. 2 from Shi et al., 2019
blood plasma testosterone increased amount, abnormal pomcaihb408/ihb408 standard conditions Table 2 from Shi et al., 2019
muscle amino acid catabolic process decreased rate of occurrence, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
whole organism increased weight, ameliorated pomcaihb408/ihb408 chemical treatment by environment: AZD-8055 Fig. 4 from Shi et al., 2019
blood plasma 3',5'-cyclic AMP increased amount, abnormal pomcaihb408/ihb408 standard conditions Table 2 from Shi et al., 2019
head kidney cyp19a1a expression increased amount, abnormal pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
whole organism increased length, abnormal pomcaihb408/ihb408 standard conditions Fig. 3Table 2 from Shi et al., 2019
eating behavior increased occurrence, abnormal pomcaihb408/ihb408 standard conditions Fig. 1Table 2 from Shi et al., 2019
whole organism increased length, abnormal pomcaihb408/ihb408 increased food availability Fig. 3 from Shi et al., 2019
aerobic respiration rate, abnormal pomcaihb408/ihb408 standard conditions Fig. 2Table 2 from Shi et al., 2019
aerobic respiration decreased rate, abnormal pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
muscle hyperplastic, abnormal pomcaihb408/ihb408 standard conditions Fig. 4 from Shi et al., 2019
trunk musculature ab1-rps6 labeling increased amount, abnormal pomcaihb409/ihb409 standard conditions Fig. 4 from Shi et al., 2019
hypophysis pomca expression decreased amount, abnormal pomcaihb409/ihb409 standard conditions Fig. 1 from Shi et al., 2019
hypothalamus pomca expression decreased amount, abnormal pomcaihb409/ihb409 standard conditions Fig. 1 from Shi et al., 2019
trunk musculature ab5-akt labeling increased amount, abnormal pomcaihb409/ihb409 standard conditions Fig. 4 from Shi et al., 2019
interrenal gland hsd3b1 expression decreased distribution, abnormal pomcaihb409/ihb409 standard conditions Fig. 2 from Shi et al., 2019
aerobic respiration decreased rate, abnormal cyp17a1ihb144/ihb144; pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
whole organism lipid increased amount, ameliorated cyp17a1ihb144/ihb144; pomcaihb408/ihb408 standard conditions Fig. 6 from Shi et al., 2019
Citations